| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | Dexcom G4 Platinum and G5 Mobile Continuous Glucose Monitoring Systems |
| Generic Name | Sensor, glucose, invasive |
| Applicant | Dexcom, Inc. 6340 Sequence Dr. San Diego, CA 92121 |
| PMA Number | P120005 |
| Supplement Number | S071 |
| Date Received | 02/27/2018 |
| Decision Date | 03/27/2018 |
| Withdrawal Date | 03/20/2026 |
| Product Code |
MDS |
| Advisory Committee |
Clinical Chemistry |
| Clinical Trials | NCT01514292
|
| Supplement Type | 30-Day Notice |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement Removal of redundant inspection of the skived wire component, which will be processed further to manufacture the finished sensor probes. The sensors are components of the Dexcom G4 PLATINUM and Dexcom G5 Mobile Continuous Monitoring Systems. |
|
|